newsfilter
← Latest News
Business Wire·

TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update

Revenues of $8.3 Million in Q4 and $29.4 Million for Full-Year 2024, Representing Growth of 44% And 59%, Respectively, Versus the Prior Year Periods Gross Margin of 85% and 86% for Q4 and Full-Year